China National Medicines (SHSE:600511) Construction In Progress : ¥2 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Construction In Progress?

China National Medicines's quarterly construction in progress declined from Sep. 2023 (¥36 Mil) to Dec. 2023 (¥3 Mil) and declined from Dec. 2023 (¥3 Mil) to Mar. 2024 (¥2 Mil).

China National Medicines's annual construction in progress declined from Dec. 2021 (¥57 Mil) to Dec. 2022 (¥36 Mil) and declined from Dec. 2022 (¥36 Mil) to Dec. 2023 (¥3 Mil).

China National Medicines Construction In Progress Historical Data

The historical data trend for China National Medicines's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Construction In Progress Chart

China National Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

12.12

13.24

57.09

36.21

2.54

China National Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															35.75	36.07	36.07	2.54	1.91

China National Medicines Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

China National Medicines (SHSE:600511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

China National Medicines (SHSE:600511) Headlines

No Headlines